Antioxidative Nanotech Product TMA-Zeolite Reduces Oxidative Stress in Cancer and Diabetic Patients:
Free radicals are highly reactive molecules that are derived from oxygen. Numerous study results from the past decades have shown that the accumulation of reactive free radicals has an important role in several pathological processes. Inflammation and hemorrhagic shock are just a few of these processes. Moreover, free radicals have been shown to also cause the onset of diabetes and even several types of cancer. Recently, a team of researchers has tried to determine whether the damage done by free radicals can be prevented or stopped by TMA-Zeolite. TMA stands for “tribomechanically activated”, and it refers to the process used in obtaining the active zeolite. Recent study results show that TMA-Zeolite is a very powerful antioxidant. The current research focuses solely on discovering whether TMA-Zeolite can have a positive effect in patients with cancer or diabetes.
A total of 176 patients were studied throughout the research. Out of the 176 patients, 114 had a type of cancer (gastrointestinal, lung, or brain tumors) while the remaining 62 were suffering from diabetes. Each patient had their blood tested prior to the beginning of the research and one month after the end of the trial. In order to measure the quantities of antioxidants, the Flandox Total Antioxidant Status kit was used. The use of this kit allowed for a correct measurement of the levels of superoxide dismutase, glutathione reductase, and glutathione peroxidase. These 3 major antioxidants are innate, enzymatic antioxidants that can be found in every human organism. In order to analyze the levels and effect of TMA-Zeolite, scientists used the free radical analytical system.
In the cancer patient batch, 53 suffered from a type of gastrointestinal cancer, 40 suffered from a type of lung cancer, and 21 patients had a type of brain cancer. The initial evaluation done with the Flandox TOtal Antioxidant Status kit showed a mean value of 1.23 mmol/L. The subsequent blood draw after one month of treatment with TMA-Zeolite showed a mean increase of 42%. On the other hand, through the use of the free radical analytical system, scientists discovered that the quantity of circulating free radicals had dropped by approximately 27%.
In the diabetes patient batch, the initial quantity of antioxidants was 1.26 mmol/L. The subsequent 1 month evaluation showed that the levels of circulating antioxidants had risen to 1.47 mmol/L. The researcher team postulates that the smaller increase of antioxidant levels in the diabetes patients is closely related to the fact that lower doses of TMA-Zeolite were administered to these patients. However, regardless of the discrepancy, both patient batches showed an increase in antioxidant values and a decrease in the amount of circulating free radicals. These initial results further strengthen the claim that a decrease in free radicals and oxidative stress can improve the outcome of patients suffering from diabetes of several types of cancer.